BCAR1 CLIA Kit

Produktnummer ABIN5669040

Produktdetails BCAR1 CLIA Kit

Target: BCAR1 (Breast Cancer Anti-Estrogen Resistance 1 (BCAR1))

Reaktivität: Human

Nachweismethode: Chemiluminescent

Methodentyp: Sandwich ELISA

Detektionsbereich: 31.25 pg/mL - 2000 pg/mL

Untere Nachweisgrenze: 31.25 pg/mL

Applikation: ELISA

Analytische Methode: Quantitative

Sensitivität: 18.75 pg/mL

Bestandteile: - Micro CLIA Plate
- Reference Standard
- Concentrated Biotinylated Detection Ab (100×)
- Concentrated HRP Conjugate (100×)
- Reference Standard & Sample Diluent
- Biotinylated Detection Ab Diluent
- HRP Conjugate Diluent
- Concentrated Wash Buffer (25×)
- Substrate Reagent A
- Substrate Reagent B
- Plate Sealer
- Product Description
- Certificate of Analysis

Anwendungsinformationen

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: The unopened kit can be stored at 4 ℃ for 1 week. If the kit is not used within 1 week, store the items separately according to the special conditions since the kit is received.

Antigendetails

Target: BCAR1 (Breast Cancer Anti-Estrogen Resistance 1 (BCAR1))

Andere Bezeichnung: Breast Cancer Anti Estrogen Resistance 1 (BCAR1 Produkte)

Synonyme: CAS CLIA Kit, CAS1 CLIA Kit, CASS1 CLIA Kit, CRKAS CLIA Kit, P130Cas CLIA Kit, AI385681 CLIA Kit, Cas CLIA Kit, Crkas CLIA Kit, P130CAS CLIA Kit, MGC68466 CLIA Kit, cas CLIA Kit, p130cas CLIA Kit, BCAR1 CLIA Kit, fc17f11 CLIA Kit, wu:fc17f11 CLIA Kit, zgc:175192 CLIA Kit, BCAR1, Cas family scaffolding protein CLIA Kit, breast cancer anti-estrogen resistance 1 CLIA Kit, breast cancer anti-estrogen resistance 1 L homeolog CLIA Kit, breast cancer anti-estrogen resistance protein 1 CLIA Kit, BCAR1 CLIA Kit, Bcar1 CLIA Kit, bcar1.L CLIA Kit, bcar1 CLIA Kit, LOC100435586 CLIA Kit

Pathways: EGFR Signaling Pathway, Neurotrophin Signalübertragung, CXCR4-mediated Signaling Events, Platelet-derived growth Factor Receptor Signaling